Enanta Pharmaceuticals, Inc.

NasdaqGS:ENTA Stock Report

Market Cap: US$264.0m

Enanta Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:ENTA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
13 Dec 23SellUS$139,490Terry VanceIndividual15,295US$9.12
05 Dec 23SellUS$23,228Nathaniel GardinerIndividual2,412US$9.63
05 Dec 23SellUS$69,625Jay LulyIndividual7,230US$9.63
05 Dec 23SellUS$20,464Tara KiefferIndividual2,125US$9.63
05 Dec 23SellUS$23,228Paul MellettIndividual2,412US$9.63
05 Dec 23SellUS$23,228Yat OrIndividual2,412US$9.63
05 Dec 23SellUS$20,464Brendan LuuIndividual2,125US$9.63
05 Dec 23SellUS$5,142Scott RottinghausIndividual534US$9.63

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ENTA?
Owner TypeNumber of SharesOwnership Percentage
State or Government00%
Private Companies6,5010.0292%
Individual Insiders1,319,5165.93%
Hedge Funds6,489,97329.2%
Institutions14,427,50664.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 90.89% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.76%
Armistice Capital LLC
2,064,000US$25.8m-1.71%0.72%
9.57%
Farallon Capital Management, L.L.C.
2,025,000US$25.3m8%0.19%
9.14%
BlackRock, Inc.
1,934,711US$24.1m-2.24%no data
8.48%
The Vanguard Group, Inc.
1,793,786US$22.4m8.03%no data
6.22%
Millennium Management LLC
1,314,949US$16.4m71.9%0.02%
5.13%
Krensavage Asset Management, LLC
1,086,024US$13.6m46.2%5.14%
4.98%
Morgan Stanley, Investment Banking and Brokerage Investments
1,052,752US$13.1m200%no data
4.42%
Northern Trust Global Investments
935,493US$11.7m-2.54%no data
3.98%
Acadian Asset Management LLC
842,944US$10.5m53.6%0.03%
3.52%
Jay Luly
743,884US$9.3m0.52%no data
3.02%
D. E. Shaw & Co., L.P.
638,168US$8.0m76.8%0.01%
2.76%
Assenagon Asset Management S.A.
583,658US$7.3m-7.59%0.02%
2.65%
Jacobs Levy Equity Management Inc
561,021US$7.0m62.3%0.04%
2.64%
Renaissance Technologies LLC
558,500US$7.0m21.9%0.01%
2.03%
Geode Capital Management, LLC
429,237US$5.4m4.77%no data
2.01%
State Street Global Advisors, Inc.
425,640US$5.3m-5.45%no data
1.66%
Yat Or
352,245US$4.4m0.74%no data
1.57%
Two Sigma Investments, LP
332,232US$4.1m56.7%0.01%
1.42%
Tang Capital Management, LLC
300,000US$3.7m0%0.45%
1.37%
Two Sigma Advisers, LP
290,800US$3.6m120%0.01%
1.16%
UBS Asset Management AG
245,299US$3.1m-16.1%no data
0.96%
AQR Capital Management, LLC
203,212US$2.5m47.5%no data
0.89%
Qube Research & Technologies Ltd
188,828US$2.4m66.1%0.01%
0.85%
Dimensional Fund Advisors LP
179,563US$2.2m-8.74%no data
0.7%
Charles Schwab Investment Management, Inc.
147,331US$1.8m0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.